The muscarinic receptor of heart cell membranes Association with agonists, antagonists and antiarrhythmic agents  by Cavey, D. et al.
Volume 84, number 1 FEBS LETTERS December 1977 
THE MUSCARINIC RECEPTOR OF HEART CELL MEMBRANES 
Association with agonists, antagonists and ant ia r rhythmic  agents 
D. CAVEY, J. P. VINCENT and M. LAZDUNSKI 
Centre de Biochimie, Facultd des Sciences, Universitd e Nice, Parc Valrose - 06034 Nice, France 
Received 7 October 1977 
1. Introduction 
The adult heart is innervated by the sympathetic 
and parasympathetic branches of the autonomic 
nervous ystem (review [1]). The pharmacological 
properties of the acetylcholine r ceptor in the heart 
are those of a receptor of the muscarinic type [2]. 
A large body of evidence suggests that acetylcholine 
shortens the action potential duration of atrial 
myocardium by increasing the potassium permeability 
of the membrane [3]. The shortening of the plateau 
by acetylcholine diminishes calcium influx during the 
action potential and this has been held responsible 
for the negative inotropic effect of the neurotrans- 
mitter [4]. 
The availability of receptor specific ligands radio- 
labelled to a high specific activity makes it now 
possible to measure directly the association properties 
of agonists and antagonists o neurotransmitter 
receptors. 3-Quinuclidinyl benzilate (QNB), a potent 
muscarinic antagonist in the central [5] and peripheral 
nervous ystem [6] has already been shown to bind 
to guinea pig ileum [7] and rat brain [8] in a very 
specific way. This paper makes use of [3 H] QNB to 
analyse the molecular properties of the heart musca- 
rinic cholinergic receptor in its interaction with ago- 
nists and antagonists. 
2. Materials and methods 
Heart membranes were prepared according to [9]. 
The final pellets were kept frozen at -15°C and re- 
suspended in 50 mM Tris at pH 7.4 before use. 
Binding experiments were carried out as described [8] 
for membrane fractions isolated from the central 
nervous ystem. [3H] QNB (8.4 Ci/mmol) was pur- 
chased from Amersham Searle. Naja mossambica 
mossambica neurotoxin I was prepared in this 
laboratory as described [10]. Protein was determined 
by the method [11 ] using bovine serum albumin as a 
standard. 
3. Results 
Figure 1 shows that binding of [aH]QNB to heart 
membranes is a saturable process. Half-maximal 
saturation (K0.5) occurs at 0.12 nM [aH] QNB. The 
maximal binding capacity is 190 fmol QNB specifi- 
cally associated/mg whole-heart proteins. The Hill 
coefficient measured for this binding is 1.0 and 
indicates no cooperativity. The simplest mechanism 
of association of QNB to its receptor (R) is therefore 
to be written: 
ka 
R + QNB ~ R - QNB 
kd 
Rates of association (ka) and dissociation (kd) 
were measured at different emperatures. The associa- 
tion process follows bimolecular kinetics (fig.2A). 
The dissociation process was followed by first incubat- 
flag heart membranes with [nH]QNB at 25°C for 
60 rain and then incubating with 10 #M atropine to 
displace the radioactive label. A parallel evaluation of 
the rate of receptor degradation was carried out by 
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Fig. 1. Binding of [ 3 H] QNB to rat heart membranes. Increasing 
amounts of [3H]QNB (from 4000-250 000 cpm) were 
incubated 60 rain at 25°C with heart membranes (0.25 mg 
protein/ml) in 2 ml 50 mM phosphate buffer at pH 7.4. The 
experiment was first carded out in the absence of atropine 
to measure the total binding capacity (D), then in the presence 
of 10/aM atropine to measure the non-specific binding not 
displaceable by the antagonist (o), the specific binding being 
measured by the difference between the two curves (e). 
Bound radioactivity was separated from free radioactivity by 
filtration on GF/B Whatman filters. The filters were placed 
in vials containing 8 ml picofluor (Packard) and the radio- 
activity was then measured by liquid scintillation spectrom- 
etry (Packard Tri-carb model B 2450) at a counting 
efficiency of 40-45%. 
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Fig.2. Time course of the [3H]QNB association with rat heart membranes (A) and of [3H]QNB dissociation from the QNB- 
muscarinic receptor complex (B) at 35°C, pH 7.4. 
(A) Specific [3H]QNB binding was measured as described in the legend of Fig.1. Inset: evaluation of the bimolecular rate constant 
for the QNB-receptor association. The equation of the curve is: 
[QNB]o -x  [QNB]o - [Rol [QNB] o 
log ( ) = k a t + log - -  
[R 0 - x 2.3 [Ro ] 
where [QNB] 0 is the concentration f [3 H]QNB added at t = 0; [R 0 ], the receptor concentration present in the tissue and x the 
concentration f specifically-bound [SH]QNB. 
[QNB] o - x 
y= 
[R01 -x  
(B) [3H] QNB is first associated with the rat heart membrane at25°C, pH 7.4 during 60 rain. The displacement of the specifically 
bound [3H]QNB is started with 10 uM atropine. Aliquots are taken at different times to measure the amount of [3H]QNB which 
remains bound to the membrane. Inset: first-order representation f the [~ H] QNB dissociation i duced by atropine, log% means 
log% of specifically-bound [3H]QNB. 
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Fig.3. Arrhenius plots of the rate constant of association k a 
(o), and of dissociation, k d (o), corresponding tothe forma- 
tion of the [3HI QNB-receptor complex. 
looking at the amount of [3H] QNB which remains 
bound to the membrane in the absence of atropine. 
No degradation occurred at 20°C. Degradation occurred 
at higher temperatures: it was 15% initial receptor 
concentration after 5 h at 25°C, 25% after 150 min 
at 30°C, 35% after 100 min at 35°C and 50% after 
50 min at 40°C. After adequate corrections for 
receptor degradation, the displacement of [3HI QNB 
by atropine can be represented as in fig.2B. As 
expected this displacement follows f'trst order kinetics. 
Values ofka,  the second order rate constant of 
association, and k d, the first order rate constant of 
dissociation, are strongly temperature-dependent. 
Arrhenius plots shown in fig.3 give enthalpies of 
activation for both processes. AH a 13.8 kcal. tool-1 
and AH] 24.3 kcal. mol -~ . The enthalpy of  binding 
of  QNB to its receptor is 2xH ° = AH* - AH~ = 
--10 kcal. mo1-1 . At 25°C, AG ° -- 14.5 kcal. mo1-1 
and AS ° + 13.5 entropy units. 
Similarly to atropine, a variety of  pharmacological- 
ly related muscarinic drugs have the ability to displace 
[3H] QNB from heart membranes (fig.4). Muscarinic 
agonists axe considerably less potent to displace 
[3 H] QNB than antagonists (fig.4 and table 1). 
Muscarinic agonists like pilocarpine, acetylcholine, 
carbamylcholine, or muscarinic antagonists like QNB, 
scopolamine and atropine show a much better 
affinity for the acetylcholine receptor of  the heart 
membrane than nicotinic agents uch as nicotine, 
dime thylphenylpiperazinium, phenyltrimethylammo- 
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Fig.4. Displacement ofspecific [3H]QNB binding by various 
concentrations ofscopolamine (o-o), atropine (o-e), ace- 
tylcholine (D--D), carbamylcholine (w-m) and Naja mossam- 
bica mossambica neurotoxin 1 (A--£X). [3H]QNB (0.6 nM) 
was incubated 60 rain at 25°C with rat heart membranes 
(0.2 mg protein/ml) in 2 m150 mM phosphate buffer at pH 7.4 
in the presence of the indicated concentrations ofcholinergic 
drugs. In the particular case of acetylcholine, 10 ~zM eserine 
had to be added to the medium to inhibit acetylcholinesterase 
activity and thus prevent acetylcholine hydrolysis. 
nium, decamethonium, d-tubocurarine or mecamyl- 
amine or the Na/a mossambica rnossambica neuro- 
toxin I (table 1). 
Antiarrhythmic drugs like verapamil and D600 
were also assayed for their ability to displace [3 H] QNB 
from its receptor site. Verapamil and D600 displaced 
specific [3H]QNB binding with EDs0 of 19/aM and 
24/aM, respectively. 
4. Discussion 
The binding characteristics of [3H]QNB to heart 
membranes (K0. 5 values, and rate constants k a and 
kd) are very similar to those found for the muscarinic 
receptor in rat brain or in guinea-pig ileum [7,8]. The 
apparent dissociation constant of the acetylcholine- 
receptor complex is of the order of 1/aM and the best 
antagonist is QNB itself with a dissociation constant 
of the receptor-QNB complex as low as 0.1 nM. One 
interesting difference between antagonists and agonists 
resides in the fact that antagonists bind to the 
muscarinic receptor with a Hill coefficient of 1, i.e., 
without any indication of cooperativity, whereas 
112 
Volume 84, number 1 FEBS LETTERS December 1977 
Table 1 
Relative potencies of cholinergic drugs and antiarrhythmic 
agents in displacing [3H]QNB binding from rat heart 
membranes 
EDso (nM) n H K0. 5 (nM) 
Muscarinic agonists 
pilocarpine 12,000 0.58 
acetylcholine 1250 0.50 
carbamylcholine 20,000 0.56 
Muscarinic antagonists 
QNB - 1.0 0.12 
scopolamine 11.0 1.0 1.4 
atropine 13.0 1.0 2.2 
Nicotinic agonists 
nicotine (a) 
dimethylphenyl- 
piperazinium (a) 
phenyltrimethyl- 
ammonium (a) 
Nicotinic antagonists 
decamethonium 10,000 - - 
d-tubocurarine 10,000 - - 
mecamylamine (b) - - 
Naja mossambica 
mossambica neuro- 
toxin I (a) - - 
Antiarrhythmic drugs 
verapamil 18,600 0.70 
D600 23,200 0.81 
a 10-20% displacement at 10 uM 
b No displacement at 10 uM 
EDs0 is the concentration f unlabelled rug which induces 
half-displacement of specifically-bound [ 3 H] QNB. K0. 5 is the 
apparent dissociation constant of the complex formed 
between heart membranes and the unlabelled rug. When the 
Hill number is 1.0, K0. 5 is calculated from the EDs0 value by 
the formula: 
[QNB] 
EDs0 = K0. 5 (1 + ~QNB ' 
where [QNB] is the concentration f free [aH]QNB at half 
dissociation and KQN B is the dissociation constant of the 
QNB-heart membranes complex 
agonists display a marked negative cooperativity of 
binding (table 1) with Hill coefficients of 0.5-0.6.  
The dissociation constant measured for QNB 
binding from kinetic data (K0. 5 = kd/ka) is of 0.03 nM 
at 25°C, very similar to the constant measured 
through direct binding experiments (fig. 1). The rate 
constant k a for the association of QNB to its receptor 
is 1.1 × 106 M -1 s -1 at 20°C. This rate constant is
several orders of magnitude lower than what would 
be expected for a diffusion controlled process 
( I0 s -109 M -1 s -1 ). Therefore it indicates that binding 
of QNB to the muscarinic receptor involves a con- 
formational rearrangement of the complex [12]. Such 
an interpretation is confirmed by the fairly large 
change of entropy (AS ° = + 13.5 entropy unit) 
involved in the binding process. 
Drugs like verapamil and D600 are well known in 
antiarrhythmic therapy. Their primary effect is 
generally believed to be due to a direct interaction of 
the molecule with the Ca 2 ÷ entry systems of the 
cardiac cell membrane [13-15].  It is clear from the 
results hown in table 1 that drugs like D600 or 
verapamil bind fairly tightly to the muscarinic receptor 
(EDso 20-40/ iM)  and that part of their clinical 
action may be due to this interaction. 
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